The wake of addiction: Pharmacological strategies for sleep disturbances in stimulant use disorders, a systematic review.
The wake of addiction: Pharmacological strategies for sleep disturbances in stimulant use disorders, a systematic review.
Systematic review identifies limited but promising pharmacological options for treating sleep disturbances in cocaine and methamphetamine use disorders.
This systematic review establishes that sleep disturbances in stimulant use disorders have been studied with pharmacological interventions, though the evidence base remains limited with only 18 qualifying studies. The review methodology appears rigorous, employing PRISMA guidelines and demonstrating good interrater reliability for bias assessment.
Sleep disturbances are common and clinically significant complications in stimulant use disorders that can perpetuate addiction cycles and complicate recovery. Having a systematic evaluation of pharmacological treatment options provides clinicians with evidence-based guidance for addressing this challenging aspect of stimulant use disorder management.
| Study Type | Systematic Review |
| Population | Adults with cocaine use disorder (CUD) or methamphetamine use disorder (MUD), n=678 across 18 studies |
| Intervention | Various pharmacological treatments for sleep disturbances |
| Comparator | Control conditions varied by included study |
| Primary Outcome | Night-time sleep outcomes measured with rigorous assessment tools |
| Key Finding | 18 studies met inclusion criteria with good interrater reliability for bias assessment |
| Journal | Drug and Alcohol Dependence |
| Year | 2025 |
While pharmacological interventions for sleep disturbances in stimulant use disorders have been studied, the limited number of qualifying studies suggests this remains an area with significant evidence gaps. The rigorous methodology of this review provides a foundation for understanding current treatment options and identifying research priorities.
The abstract does not reveal which specific pharmacological interventions were studied, their relative efficacy, or safety profiles. Without access to the full results, we cannot determine which medications showed benefit or how clinically meaningful any improvements were.
With only 18 studies across two distinct stimulant use disorders and a total population of 678 participants, the evidence base appears relatively small. The heterogeneity of study designs, populations, and interventions likely limits the ability to draw definitive conclusions about optimal treatment approaches.
This systematic review represents a methodologically sound attempt to synthesize evidence on pharmacological sleep interventions in stimulant use disorders. However, the limited number of studies highlights the need for more research rather than providing clear clinical guidance at this point.
Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
How common are sleep disturbances in patients with cocaine and methamphetamine use disorders?
Sleep disturbances are highly prevalent in stimulant use disorders, affecting the majority of patients during both active use and withdrawal phases. These sleep problems can persist for weeks to months during recovery and significantly impact treatment outcomes and relapse risk.
What pharmacological treatments show promise for sleep problems in stimulant use disorders?
This systematic review identified 18 studies examining various pharmacological interventions, though the evidence base remains limited with only 678 total participants across all studies. The review found some promising options, but more robust clinical trials are needed to establish clear treatment guidelines.
Should sleep medications be prescribed differently for cocaine versus methamphetamine use disorders?
The review included 11 studies in cocaine use disorder and 7 in methamphetamine use disorder, suggesting potential differences in treatment approaches. However, more research is needed to determine if specific medications work better for one stimulant versus another.
Are there safety concerns when prescribing sleep medications to patients with stimulant use disorders?
Prescribing sleep medications to patients with substance use disorders requires careful consideration of abuse potential and drug interactions. Clinicians should prioritize non-addictive options and closely monitor patients for misuse, especially given the complex neurochemical effects of stimulant withdrawal.
How should clinicians measure sleep outcomes when treating patients with stimulant use disorders?
The review only included studies using rigorous sleep measurement tools, emphasizing the importance of objective assessment methods. Clinicians should use validated sleep scales, sleep diaries, or consider sleep studies rather than relying solely on subjective patient reports to properly evaluate treatment effectiveness.
